KUALA LUMPUR: Malaysia has been featured as the Hepatitis C Treatment Hub of Asia at Expo 2020 Dubai during the opening ceremony of Malaysia Healthcare Excellence week at the Malaysia Pavilion, according to the Malaysia Healthcare Travel Council (MHTC).
MHTC said being the first country in the world to be given conditional approval for Ravidasvir in combination with Sofosbuvir to treat Hepatitis C, Malaysia was ready to offer access to an affordable and efficacious treatment solution.
“In response to the 2021 World Hepatitis Day theme, ‘Hepatitis Can’t Wait’, Malaysia is ready and raring to move forward with a treatment solution for those infected with the disease.
“Malaysia is offering Hepatitis C patients a treatment with a cure rate of 97% and cost reduction of 95%,” MHTC chief executive officer Mohd Daud Mohd Arif said yesterday at the opening ceremony of Malaysia Healthcare Excellence week, reported Bernama.
Meanwhile, Pharmaniaga Bhd group managing director Datuk Zulkarnain Md Eusope said: “Through our expertise in supply, logistics and distribution of Hepatitis C drug to MHTC’s member hospitals, we are proud to contribute to the shared goal of both Malaysia and the World Health Organisation to eliminate Hepatitis C by 2030.”
